| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.861 | 0.008 | 0.917 | Antiinflammatory | 0.917 0.005 CID_131769945 | CID_131769945 | |
| 0.673 | 0.005 | 0.673 | Superoxide dismutase inhibitor | 0.173 0.151 CID_131769945 | ||
| 0.668 | 0.01 | 0.77 | Cholesterol antagonist | 0.77 0.005 CID_131769945 | CID_131769945 | |
| 0.656 | 0.004 | 0.656 | Amyloid beta precursor protein antagonist | 0.312 0.014 CID_131769945 | ||
| 0.624 | 0.004 | 0.624 | Cyclooxygenase 1 inhibitor | 0.452 0.005 CID_131769945 | ||
| 0.633 | 0.015 | 0.633 | Aldehyde oxidase inhibitor | |||
| 0.607 | 0.004 | 0.607 | Anesthetic general | 0.592 0.005 CID_131769945 | ||
| 0.566 | 0.005 | 0.849 | Non-steroidal antiinflammatory agent | 0.849 0.003 CID_131769945 | CID_131769945 | |
| 0.583 | 0.033 | 0.824 | Transcription factor NF kappa B inhibitor | 0.824 0.011 CID_131769945 | CID_131769945 | |
| 0.534 | 0.015 | 0.534 | Lipoxygenase inhibitor | |||
| 0.508 | 0.006 | 0.508 | Phospholipase C inhibitor | 0.289 0.019 CID_131769945 | ||
| 0.504 | 0.005 | 0.504 | Calcium channel activator | 0.243 0.155 CID_131769945 | ||
| 0.538 | 0.039 | 0.538 | Analgesic | 0.221 0.213 CID_131769945 | ||
| 0.502 | 0.009 | 0.502 | Peroxidase inhibitor | |||
| 0.533 | 0.041 | 0.759 | Cyclophilin D inhibitor | 0.759 0.009 CID_131769945 | CID_131769945 | |
| 0.471 | 0.005 | 0.471 | Sodium/bile acid cotransporter inhibitor | 0.401 0.017 CID_131769945 | ||
| 0.478 | 0.016 | 0.478 | Amyloid beta aggregation inhibitor | 0.155 0.104 CID_131769945 | ||
| 0.464 | 0.004 | 0.464 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.474 | 0.018 | 0.621 | Hypoglycemic | 0.621 0.007 CID_131769945 | CID_131769945 | |
| 0.459 | 0.004 | 0.687 | Cyclooxygenase 3 inhibitor | 0.687 0.002 CID_131769945 | CID_131769945 | |
| 0.456 | 0.005 | 0.456 | Cyclooxygenase inhibitor | 0.349 0.011 CID_131769945 | ||
| 0.473 | 0.023 | 0.635 | Antioxidant | 0.635 0.009 CID_131769945 | CID_131769945 | |
| 0.455 | 0.007 | 0.455 | 5 Hydroxytryptamine uptake stimulant | 0.203 0.145 CID_131769945 | ||
| 0.479 | 0.036 | 0.541 | Histamine release inhibitor | 0.541 0.018 CID_131769945 | CID_131769945 | |
| 0.441 | 0.005 | 0.457 | Interleukin 6 antagonist | 0.457 0.005 CID_131769945 | CID_131769945 | |
| 0.448 | 0.022 | 0.585 | Free radical scavenger | 0.585 0.009 CID_131769945 | CID_131769945 | |
| 0.487 | 0.065 | 0.495 | Caspase 9 stimulant | 0.495 0.062 CID_131769945 | CID_131769945 | |
| 0.419 | 0.005 | 0.419 | Chelator | 0.214 0.022 CID_131769945 | ||
| 0.427 | 0.02 | 0.471 | Hypolipemic | 0.471 0.015 CID_131769945 | CID_131769945 | |
| 0.433 | 0.047 | 0.433 | Thyroid hormone antagonist | |||
| 0.38 | 0.004 | 0.38 | Succinate dehydrogenase inhibitor | 0.164 0.088 CID_131769945 | ||
| 0.368 | 0.01 | 0.368 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.242 0.046 CID_131769945 | ||
| 0.384 | 0.033 | 0.384 | Interleukin antagonist | 0.153 0.116 CID_131769945 | ||
| 0.382 | 0.032 | 0.388 | Antiamyloidogenic | 0.388 0.031 CID_131769945 | CID_131769945 | |
| 0.397 | 0.05 | 0.763 | Antithrombotic | 0.763 0.005 CID_131769945 | CID_131769945 | |
| 0.353 | 0.006 | 0.353 | Cystathionine beta-synthase inhibitor | 0.127 0.053 CID_131769945 | ||
| 0.412 | 0.071 | 0.412 | 5 Hydroxytryptamine release inhibitor | 0.318 0.146 CID_131769945 | ||
| 0.35 | 0.01 | 0.35 | Gastrin inhibitor | 0.269 0.059 CID_131769945 | ||
| 0.349 | 0.012 | 0.592 | Alpha-N-acetylglucosaminidase inhibitor | 0.592 0.004 CID_131769945 | CID_131769945 | |
| 0.346 | 0.012 | 0.428 | Protein kinase stimulant | 0.428 0.006 CID_131769945 | CID_131769945 | |
| 0.396 | 0.063 | 0.396 | GABA C receptor rho-3 antagonist | |||
| 0.344 | 0.013 | 0.58 | Amylase inhibitor | 0.58 0.004 CID_131769945 | CID_131769945 | |
| 0.338 | 0.011 | 0.338 | Neurotrophic factor enhancer | 0.255 0.035 CID_131769945 | ||
| 0.331 | 0.004 | 0.331 | Interleukin 8 antagonist | 0.106 0.084 CID_131769945 | ||
| 0.389 | 0.068 | 0.585 | Immunosuppressant | 0.585 0.015 CID_131769945 | CID_131769945 | |
| 0.397 | 0.083 | 0.397 | Calcium channel L-type activator | |||
| 0.364 | 0.051 | 0.364 | 12-Lipoxygenase inhibitor | |||
| 0.34 | 0.028 | 0.34 | Platelet aggregation inhibitor | 0.162 0.114 CID_131769945 | ||
| 0.321 | 0.011 | 0.321 | Cyclooxygenase 2 inhibitor | 0.252 0.02 CID_131769945 | ||
| 0.353 | 0.044 | 0.445 | Interleukin 2 agonist | 0.445 0.017 CID_131769945 | CID_131769945 | |
| 0.356 | 0.051 | 0.476 | Spasmolytic | 0.476 0.027 CID_131769945 | CID_131769945 | |
| 0.319 | 0.021 | 0.405 | Thrombolytic | 0.405 0.011 CID_131769945 | CID_131769945 | |
| 0.344 | 0.047 | 0.363 | Hypoxia-inducible factor 1 alpha inhibitor | 0.363 0.041 CID_131769945 | CID_131769945 | |
| 0.3 | 0.003 | 0.3 | Bile acid receptor antagonist | 0.172 0.005 CID_131769945 | ||
| 0.406 | 0.111 | 0.626 | Apoptosis agonist | 0.626 0.044 CID_131769945 | CID_131769945 | |
| 0.295 | 0.004 | 0.295 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.307 | 0.017 | 0.307 | Monophenol monooxygenase inhibitor | 0.246 0.025 CID_131769945 | ||
| 0.295 | 0.014 | 0.295 | Phospholipase A2 inhibitor | 0.285 0.016 CID_131769945 | ||
| 0.286 | 0.008 | 0.295 | ATPase inhibitor | 0.295 0.006 CID_131769945 | CID_131769945 | |
| 0.278 | 0.003 | 0.278 | Liver X receptor alpha agonist | |||
| 0.29 | 0.023 | 0.29 | Melanin inhibitor | 0.212 0.037 CID_131769945 | ||
| 0.277 | 0.015 | 0.338 | Insulin secretagoues | 0.338 0.009 CID_131769945 | CID_131769945 | |
| 0.275 | 0.014 | 0.275 | Cholesterol synthesis inhibitor | 0.159 0.04 CID_131769945 | ||
| 0.326 | 0.069 | 0.425 | Apoptosis antagonist | 0.425 0.032 CID_131769945 | CID_131769945 | |
| 0.297 | 0.041 | 0.439 | Nitric oxide antagonist | 0.439 0.021 CID_131769945 | CID_131769945 | |
| 0.265 | 0.009 | 0.265 | Mediator release inhibitor | 0.165 0.023 CID_131769945 | ||
| 0.299 | 0.048 | 0.395 | Interleukin agonist | 0.395 0.019 CID_131769945 | CID_131769945 | |
| 0.253 | 0.004 | 0.253 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.253 | 0.005 | 0.253 | Arachidonic acid antagonist | 0.207 0.027 CID_131769945 | ||
| 0.27 | 0.025 | 0.302 | Interferon gamma antagonist | 0.302 0.02 CID_131769945 | CID_131769945 | |
| 0.244 | 0.005 | 0.244 | Alcohol oxidase inhibitor | |||
| 0.248 | 0.013 | 0.427 | Expectorant | 0.427 0.004 CID_131769945 | CID_131769945 | |
| 0.24 | 0.006 | 0.24 | ABCA1 expression enhancer | 0.109 0.039 CID_131769945 | ||
| 0.241 | 0.007 | 0.241 | Mucolytic | 0.231 0.008 CID_131769945 | ||
| 0.238 | 0.005 | 0.238 | Macrophage migration inhibitory factor inhibitor | |||
| 0.26 | 0.029 | 0.26 | Insulin sensitizer | |||
| 0.233 | 0.005 | 0.233 | Prolactin inhibitor | |||
| 0.231 | 0.004 | 0.231 | DOPA decarboxylase inhibitor | |||
| 0.229 | 0.003 | 0.229 | GABA B receptor agonist | |||
| 0.231 | 0.005 | 0.231 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.302 | 0.081 | 0.639 | Immunomodulator | 0.639 0.008 CID_131769945 | CID_131769945 | |
| 0.237 | 0.018 | 0.237 | 5-Lipoxygenase inhibitor | |||
| 0.302 | 0.085 | 0.315 | Vasodilator, coronary | 0.315 0.076 CID_131769945 | CID_131769945 | |
| 0.225 | 0.016 | 0.225 | Farnesoid X receptor antagonist | 0.137 0.07 CID_131769945 | ||
| 0.27 | 0.061 | 0.585 | Angiogenesis stimulant | 0.585 0.007 CID_131769945 | CID_131769945 | |
| 0.231 | 0.022 | 0.374 | Hexokinase inhibitor | 0.374 0.005 CID_131769945 | CID_131769945 | |
| 0.213 | 0.008 | 0.213 | TRPA1 agonist | 0.097 0.093 CID_131769945 | ||
| 0.227 | 0.024 | 0.227 | Interleukin 1 antagonist | 0.113 0.099 CID_131769945 | ||
| 0.206 | 0.002 | 0.206 | Estrogen-related receptor beta agonist | |||
| 0.222 | 0.019 | 0.438 | Cell adhesion inhibitor | 0.438 0.005 CID_131769945 | CID_131769945 | |
| 0.209 | 0.01 | 0.209 | Vanilloid 1 agonist | 0.15 0.038 CID_131769945 | ||
| 0.274 | 0.076 | 0.274 | Insulysin inhibitor | |||
| 0.307 | 0.109 | 0.307 | Calpain 2 inhibitor | |||
| 0.319 | 0.121 | 0.614 | Antibacterial | 0.614 0.017 CID_131769945 | CID_131769945 | |
| 0.204 | 0.012 | 0.204 | GABA C receptor antagonist | |||
| 0.201 | 0.011 | 0.298 | Triose-phosphate isomerase inhibitor | 0.298 0.005 CID_131769945 | CID_131769945 | |
| 0.193 | 0.004 | 0.193 | CXC chemokine 1 receptor antagonist | 0.053 0.032 CID_131769945 | ||
| 0.197 | 0.011 | 0.197 | Creatine kinase inhibitor | |||
| 0.225 | 0.04 | 0.225 | Histone acetyltransferase inhibitor | |||
| 0.213 | 0.029 | 0.213 | Neurotensin receptor agonist | |||
| 0.202 | 0.02 | 0.202 | GABA C receptor agonist | |||
| 0.19 | 0.008 | 0.19 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.192 | 0.013 | 0.192 | Porphobilinogen synthase inhibitor | |||
| 0.283 | 0.106 | 0.283 | Vasodilator, peripheral | |||
| 0.226 | 0.052 | 0.481 | Hepatoprotectant | 0.481 0.008 CID_131769945 | CID_131769945 | |
| 0.183 | 0.01 | 0.183 | Keratolytic | |||
| 0.181 | 0.009 | 0.181 | Glutamate decarboxylase inhibitor | |||
| 0.177 | 0.005 | 0.177 | GABA aminotransferase inhibitor | 0.102 0.026 CID_131769945 | ||
| 0.228 | 0.056 | 0.274 | DNA methyltransferase I inhibitor | 0.274 0.036 CID_131769945 | CID_131769945 | |
| 0.172 | 0.005 | 0.172 | Peroxisome proliferator-activated receptor gamma antagonist | 0.072 0.047 CID_131769945 | ||
| 0.195 | 0.029 | 0.195 | Aldehyde dehydrogenase inhibitor | 0.131 0.061 CID_131769945 | ||
| 0.214 | 0.048 | 0.214 | Lipocortins synthesis antagonist | 0.17 0.08 CID_131769945 | ||
| 0.222 | 0.057 | 0.222 | Nitric-oxide synthase stimulant | |||
| 0.27 | 0.105 | 0.27 | Thyroid hormone beta antagonist | |||
| 0.179 | 0.016 | 0.179 | Estrogen antagonist | |||
| 0.19 | 0.031 | 0.19 | DNA polymerase I inhibitor | 0.174 0.038 CID_131769945 | ||
| 0.164 | 0.005 | 0.164 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.069 0.031 CID_131769945 | ||
| 0.165 | 0.01 | 0.165 | Peroxisome proliferator-activated receptor gamma agonist | 0.075 0.044 CID_131769945 | ||
| 0.18 | 0.025 | 0.18 | Adenylate cyclase stimulant | 0.129 0.103 CID_131769945 | ||
| 0.158 | 0.004 | 0.158 | Liver X receptor beta agonist | |||
| 0.185 | 0.031 | 0.185 | Toll-Like receptor 2 antagonist | |||
| 0.166 | 0.013 | 0.228 | Cell adhesion molecule inhibitor | 0.228 0.008 CID_131769945 | CID_131769945 | |
| 0.244 | 0.092 | 0.244 | 5 Hydroxytryptamine release stimulant | |||
| 0.164 | 0.013 | 0.193 | Thioredoxin inhibitor | 0.193 0.009 CID_131769945 | CID_131769945 | |
| 0.194 | 0.044 | 0.316 | Lipid peroxidase inhibitor | 0.316 0.017 CID_131769945 | CID_131769945 | |
| 0.158 | 0.009 | 0.158 | Leukotriene antagonist | 0.088 0.027 CID_131769945 | ||
| 0.165 | 0.018 | 0.166 | Ca2+-transporting ATPase inhibitor | 0.166 0.017 CID_131769945 | CID_131769945 | |
| 0.245 | 0.098 | 0.517 | Immunostimulant | 0.517 0.027 CID_131769945 | CID_131769945 | |
| 0.184 | 0.038 | 0.272 | Cell wall synthesis inhibitor | 0.272 0.012 CID_131769945 | CID_131769945 | |
| 0.163 | 0.017 | 0.163 | Histidine decarboxylase inhibitor | |||
| 0.155 | 0.01 | 0.155 | Aldose reductase inhibitor | 0.103 0.017 CID_131769945 | ||
| 0.154 | 0.01 | 0.154 | Ornithine decarboxylase inhibitor | 0.111 0.033 CID_131769945 | ||
| 0.155 | 0.01 | 0.155 | Purinergic P2X2 antagonist | 0.069 0.046 CID_131769945 | ||
| 0.149 | 0.006 | 0.149 | Peroxisome proliferator-activated receptor alpha agonist | 0.047 0.035 CID_131769945 | ||
| 0.192 | 0.05 | 0.192 | Protein-tyrosine phosphatase inhibitor | 0.153 0.075 CID_131769945 | ||
| 0.175 | 0.035 | 0.264 | Alkylator | 0.264 0.015 CID_131769945 | CID_131769945 | |
| 0.217 | 0.077 | 0.217 | RNA-directed DNA polymerase inhibitor | 0.216 0.079 CID_131769945 | ||
| 0.176 | 0.036 | 0.176 | Protein-tyrosine phosphatase 1B inhibitor | 0.149 0.046 CID_131769945 | ||
| 0.142 | 0.007 | 0.142 | NMDA receptor subunit 3B antagonist | |||
| 0.178 | 0.044 | 0.235 | Mannose-6-phosphate isomerase inhibitor | 0.235 0.016 CID_131769945 | CID_131769945 | |
| 0.156 | 0.025 | 0.193 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.193 0.017 CID_131769945 | CID_131769945 | |
| 0.158 | 0.027 | 0.158 | Photosensitizer | 0.116 0.062 CID_131769945 | ||
| 0.149 | 0.019 | 0.149 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.205 | 0.076 | 0.266 | DNA methylase inhibitor | 0.266 0.04 CID_131769945 | CID_131769945 | |
| 0.139 | 0.012 | 0.139 | Vanilloid agonist | 0.082 0.064 CID_131769945 | ||
| 0.142 | 0.018 | 0.142 | Estrogen receptor beta antagonist | |||
| 0.133 | 0.009 | 0.133 | Glycine receptor agonist | 0.104 0.019 CID_131769945 | ||
| 0.127 | 0.003 | 0.127 | Liver X receptor beta antagonist | |||
| 0.156 | 0.034 | 0.156 | Heat shock protein 70 antagonist | |||
| 0.122 | 0.002 | 0.122 | Thyroid hormone agonist | |||
| 0.213 | 0.093 | 0.341 | Platelet antagonist | 0.341 0.04 CID_131769945 | CID_131769945 | |
| 0.125 | 0.006 | 0.125 | Oleamide hydrolase inhibitor | |||
| 0.143 | 0.025 | 0.143 | Electron transport complex I inhibitor | |||
| 0.126 | 0.009 | 0.126 | Glycine transporter 2 inhibitor | |||
| 0.145 | 0.03 | 0.145 | Carbonic anhydrase III inhibitor | |||
| 0.149 | 0.038 | 0.149 | Aminopeptidase B inhibitor | |||
| 0.189 | 0.077 | 0.363 | Platelet adhesion inhibitor | 0.363 0.017 CID_131769945 | CID_131769945 | |
| 0.149 | 0.038 | 0.149 | Ferrochelatase inhibitor | |||
| 0.123 | 0.012 | 0.123 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.136 | 0.024 | 0.136 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.125 | 0.014 | 0.125 | Amidase inhibitor | |||
| 0.115 | 0.004 | 0.115 | DNA helicase inhibitor | 0.08 0.011 CID_131769945 | ||
| 0.139 | 0.029 | 0.139 | Catalase inhibitor | |||
| 0.144 | 0.035 | 0.144 | Nav1.1 sodium channel blocker | |||
| 0.134 | 0.026 | 0.134 | Alcohol dehydrogenase inhibitor | |||
| 0.111 | 0.004 | 0.111 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.142 | 0.037 | 0.142 | Nav1.4 sodium channel blocker | |||
| 0.122 | 0.018 | 0.122 | Estrogen receptor alpha antagonist | |||
| 0.136 | 0.033 | 0.136 | Adenylate kinase inhibitor | 0.101 0.066 CID_131769945 | ||
| 0.307 | 0.204 | 0.307 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.132 | 0.029 | 0.132 | Anabolic | |||
| 0.162 | 0.062 | 0.368 | NOS3 expression enhancer | 0.368 0.01 CID_131769945 | CID_131769945 | |
| 0.123 | 0.024 | 0.197 | Phosphofructokinase-1 inhibitor | 0.197 0.011 CID_131769945 | CID_131769945 | |
| 0.199 | 0.1 | 0.35 | Peptidyltransferase inhibitor | 0.35 0.012 CID_131769945 | CID_131769945 | |
| 0.133 | 0.036 | 0.352 | UDP-glucose 4-epimerase inhibitor | 0.352 0.008 CID_131769945 | CID_131769945 | |
| 0.1 | 0.005 | 0.1 | Retinoid X alpha receptor agonist | |||
| 0.228 | 0.134 | 0.243 | Caspase 3 stimulant | 0.243 0.119 CID_131769945 | CID_131769945 | |
| 0.205 | 0.111 | 0.225 | DNA damaging | 0.225 0.097 CID_131769945 | CID_131769945 | |
| 0.224 | 0.13 | 0.224 | Nootropic | |||
| 0.121 | 0.027 | 0.121 | Cathepsin G inhibitor | |||
| 0.121 | 0.028 | 0.256 | NADH dehydrogenase inhibitor | 0.256 0.008 CID_131769945 | CID_131769945 | |
| 0.12 | 0.029 | 0.12 | Metalloproteinase-2 inhibitor | |||
| 0.095 | 0.005 | 0.095 | Cholesterol esterase inhibitor | 0.05 0.03 CID_131769945 | ||
| 0.1 | 0.011 | 0.1 | Glutamate (mGluR7) antagonist | |||
| 0.105 | 0.016 | 0.105 | Estrogen agonist | |||
| 0.166 | 0.077 | 0.166 | Antipruritic | |||
| 0.092 | 0.003 | 0.092 | Free fatty acid receptor 1 antagonist | |||
| 0.094 | 0.009 | 0.094 | NMDA receptor subunit 3A antagonist | |||
| 0.124 | 0.039 | 0.162 | Toll-Like receptor 4 antagonist | 0.162 0.015 CID_131769945 | CID_131769945 | |
| 0.097 | 0.012 | 0.097 | Glutamate (mGluR6) antagonist | |||
| 0.198 | 0.116 | 0.198 | Calpain inhibitor | |||
| 0.106 | 0.025 | 0.106 | Aminopeptidase I inhibitor | |||
| 0.145 | 0.063 | 0.145 | Pregnane X receptor agonist | |||
| 0.09 | 0.009 | 0.09 | Liver X receptor agonist | |||
| 0.128 | 0.048 | 0.128 | Caspase 3 inhibitor | |||
| 0.086 | 0.007 | 0.086 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.143 | 0.064 | 0.158 | Bone formation stimulant | 0.158 0.053 CID_131769945 | CID_131769945 | |
| 0.081 | 0.002 | 0.081 | Thyroid hormone beta agonist | |||
| 0.106 | 0.028 | 0.106 | Glutamate dehydrogenase inhibitor | |||
| 0.09 | 0.012 | 0.09 | Plasminogen activator inhibitor antagonist | |||
| 0.082 | 0.004 | 0.082 | ATP citrate lysase inhibitor | |||
| 0.134 | 0.056 | 0.134 | Proteasome inhibitor | |||
| 0.103 | 0.026 | 0.103 | D-Ala-D-Ala ligase inhibitor | |||
| 0.135 | 0.06 | 0.135 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.081 | 0.006 | 0.081 | AMPA 4 receptor antagonist | |||
| 0.081 | 0.007 | 0.081 | Retinoid X receptor agonist | |||
| 0.085 | 0.012 | 0.085 | Aconitate hydratase inhibitor | |||
| 0.183 | 0.111 | 0.183 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.119 | 0.046 | 0.119 | Urease inhibitor | |||
| 0.131 | 0.059 | 0.131 | Adenylate cyclase inhibitor | 0.106 0.079 CID_131769945 | ||
| 0.148 | 0.076 | 0.148 | GABA C receptor rho-2 antagonist | |||
| 0.087 | 0.016 | 0.093 | Nitric oxide donor | 0.093 0.013 CID_131769945 | CID_131769945 | |
| 0.17 | 0.1 | 0.17 | Pyruvate kinase inhibitor | |||
| 0.136 | 0.065 | 0.136 | Interleukin 4 antagonist | |||
| 0.104 | 0.034 | 0.104 | Glutathione S-transferase inhibitor | |||
| 0.104 | 0.035 | 0.114 | ATPase (Vacuolar H+) inhibitor | 0.114 0.024 CID_131769945 | CID_131769945 | |
| 0.114 | 0.045 | 0.114 | Folate antagonist | 0.092 0.081 CID_131769945 | ||
| 0.086 | 0.017 | 0.086 | Thromboxane antagonist | |||
| 0.117 | 0.049 | 0.171 | Xanthine oxidase inhibitor | 0.171 0.027 CID_131769945 | CID_131769945 | |
| 0.096 | 0.028 | 0.096 | Leukotriene synthesis inhibitor | |||
| 0.082 | 0.014 | 0.082 | Heme oxygenase stimulant | 0.058 0.054 CID_131769945 | ||
| 0.071 | 0.004 | 0.071 | Thyroid hormone alpha antagonist | |||
| 0.123 | 0.057 | 0.127 | Microtubule formation inhibitor | 0.127 0.053 CID_131769945 | CID_131769945 | |
| 0.1 | 0.035 | 0.1 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.093 | 0.029 | 0.093 | HIV-1 integrase inhibitor | |||
| 0.071 | 0.008 | 0.071 | Dopamine D5 agonist | |||
| 0.076 | 0.013 | 0.076 | 5-Alpha-reductase inhibitor | |||
| 0.072 | 0.009 | 0.072 | AICAR transformylase inhibitor | |||
| 0.155 | 0.094 | 0.155 | Catenin beta inhibitor | |||
| 0.101 | 0.04 | 0.101 | Glutamate release inhibitor | 0.096 0.049 CID_131769945 | ||
| 0.15 | 0.089 | 0.15 | Mcl-1 antagonist | |||
| 0.07 | 0.01 | 0.07 | Urate transporter 1 inhibitor | |||
| 0.084 | 0.024 | 0.084 | Argininosuccinate synthase inhibitor | |||
| 0.071 | 0.011 | 0.071 | Leukotriene A4 hydrolase inhibitor | |||
| 0.078 | 0.019 | 0.078 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.087 | 0.028 | 0.087 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.073 | 0.014 | 0.073 | Dihydroorotate oxidase inhibitor | |||
| 0.106 | 0.047 | 0.106 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.107 | 0.048 | 0.107 | Electrolyte absorption antagonist | |||
| 0.068 | 0.009 | 0.068 | Nicotinic acid receptor agonist | |||
| 0.145 | 0.086 | 0.145 | CF transmembrane conductance regulator agonist | |||
| 0.088 | 0.031 | 0.088 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.091 | 0.034 | 0.091 | CDC25A inhibitor | |||
| 0.123 | 0.067 | 0.123 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.072 | 0.015 | 0.072 | Ryanodine receptor antagonist | |||
| 0.074 | 0.018 | 0.074 | Leukotriene B4 antagonist | 0.059 0.029 CID_131769945 | ||
| 0.066 | 0.01 | 0.066 | Estrogen-related receptor alpha antagonist | |||
| 0.091 | 0.036 | 0.091 | T cell inhibitor | 0.083 0.056 CID_131769945 | ||
| 0.063 | 0.008 | 0.063 | Glutamate (mGluR3) antagonist | |||
| 0.071 | 0.018 | 0.071 | Epithelial sodium channel blocker | |||
| 0.08 | 0.028 | 0.08 | Aromatase inhibitor | |||
| 0.1 | 0.047 | 0.1 | NMDA receptor antagonist | |||
| 0.127 | 0.075 | 0.127 | Nav1.2 sodium channel blocker | |||
| 0.063 | 0.012 | 0.063 | Glutamate (mGluR group III) antagonist | |||
| 0.068 | 0.017 | 0.091 | Glucose-6-phosphate translocase inhibitor | 0.091 0.008 CID_131769945 | CID_131769945 | |
| 0.081 | 0.031 | 0.081 | Neutrophil collagenase inhibitor | |||
| 0.189 | 0.14 | 0.299 | DNA synthesis inhibitor | 0.299 0.044 CID_131769945 | CID_131769945 | |
| 0.054 | 0.005 | 0.054 | Liver X receptor alpha antagonist | |||
| 0.124 | 0.075 | 0.124 | Antibacterial (Helicobacter pylori) | 0.111 0.097 CID_131769945 | ||
| 0.07 | 0.021 | 0.07 | Thromboxane A2 antagonist | |||
| 0.064 | 0.016 | 0.099 | Glucose-6-phosphate isomerase inhibitor | 0.099 0.005 CID_131769945 | CID_131769945 | |
| 0.102 | 0.054 | 0.102 | Potassium channel (Ca-activated) activator | |||
| 0.056 | 0.008 | 0.056 | Liver X receptor antagonist | |||
| 0.075 | 0.029 | 0.075 | Biliverdin reductase inhibitor | |||
| 0.06 | 0.014 | 0.06 | Glutamate (mGluR4) antagonist | |||
| 0.054 | 0.009 | 0.054 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.065 | 0.02 | 0.065 | Leukotriene C antagonist | |||
| 0.055 | 0.009 | 0.055 | Retinoid X receptor antagonist | |||
| 0.05 | 0.005 | 0.05 | CXC chemokine 2 receptor antagonist | |||
| 0.049 | 0.005 | 0.049 | Glutamate (mGluR3) agonist | |||
| 0.075 | 0.031 | 0.075 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.065 | 0.022 | 0.065 | Thromboxane synthase inhibitor | |||
| 0.101 | 0.058 | 0.101 | Glutamate (mGluR7) agonist | |||
| 0.08 | 0.037 | 0.08 | Matrix metalloproteinase inhibitor | |||
| 0.061 | 0.018 | 0.061 | Macrophage elastase inhibitor | |||
| 0.084 | 0.041 | 0.084 | Metalloproteinase-9 inhibitor | |||
| 0.072 | 0.031 | 0.072 | NMDA 2C receptor antagonist | |||
| 0.08 | 0.039 | 0.08 | Prostaglandin-E synthase inhibitor | |||
| 0.049 | 0.008 | 0.049 | Melatonin receptor 1A agonist | |||
| 0.044 | 0.005 | 0.044 | Free fatty acid receptor 1 agonist | |||
| 0.096 | 0.057 | 0.143 | Uric acid excretion stimulant | 0.143 0.025 CID_131769945 | CID_131769945 | |
| 0.061 | 0.022 | 0.061 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.043 | 0.004 | 0.043 | Estrogen-related receptor gamma antagonist | |||
| 0.07 | 0.032 | 0.07 | Purinergic P2X1 antagonist | |||
| 0.056 | 0.018 | 0.056 | Estrogen receptor beta agonist | |||
| 0.065 | 0.027 | 0.065 | NMDA 2A receptor antagonist | |||
| 0.12 | 0.082 | 0.12 | NADPH oxidase inhibitor | |||
| 0.087 | 0.05 | 0.087 | Carbonic anhydrase VI inhibitor | |||
| 0.04 | 0.003 | 0.04 | Thyroid hormone alpha agonist | |||
| 0.066 | 0.03 | 0.066 | Botulinum neurotoxin type A inhibitor | |||
| 0.069 | 0.033 | 0.069 | Prostaglandin F2 alpha antagonist | |||
| 0.046 | 0.011 | 0.046 | Glucagon receptor antagonist | |||
| 0.045 | 0.01 | 0.045 | Retinoid X alpha receptor antagonist | |||
| 0.044 | 0.01 | 0.044 | Cholesterol ester transfer protein antagonist | |||
| 0.071 | 0.036 | 0.071 | MDM2 inhibitor | |||
| 0.044 | 0.01 | 0.07 | Uridine phosphorylase inhibitor | 0.07 0.004 CID_131769945 | CID_131769945 | |
| 0.057 | 0.024 | 0.057 | CD45 antagonist | |||
| 0.101 | 0.068 | 0.134 | Beta glucuronidase inhibitor | 0.134 0.034 CID_131769945 | CID_131769945 | |
| 0.037 | 0.005 | 0.037 | ICAM 1 antagonist | |||
| 0.098 | 0.065 | 0.098 | GABA C receptor rho-1 antagonist | |||
| 0.069 | 0.037 | 0.069 | NMDA receptor agonist | |||
| 0.062 | 0.03 | 0.062 | Prostaglandin antagonist | |||
| 0.042 | 0.01 | 0.042 | Lysine carboxypeptidase inhibitor | |||
| 0.062 | 0.031 | 0.062 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.048 | 0.017 | 0.048 | Kainate receptor agonist | |||
| 0.048 | 0.018 | 0.048 | Estrogen receptor alpha agonist | |||
| 0.072 | 0.041 | 0.355 | Selectin antagonist | 0.355 0.004 CID_131769945 | CID_131769945 | |
| 0.08 | 0.05 | 0.105 | Na+ K+ transporting ATPase inhibitor | 0.105 0.027 CID_131769945 | CID_131769945 | |
| 0.064 | 0.034 | 0.064 | Beta 2 adrenoreceptor agonist | |||
| 0.035 | 0.007 | 0.035 | Prostaglandin F2 alpha agonist | |||
| 0.066 | 0.037 | 0.066 | Caspase 9 inhibitor | |||
| 0.053 | 0.024 | 0.053 | Dopamine beta hydroxylase inhibitor | |||
| 0.1 | 0.071 | 0.238 | AMP-activated protein kinase stimulant | 0.238 0.007 CID_131769945 | CID_131769945 | |
| 0.045 | 0.016 | 0.045 | Glutamate (mGluR8) agonist | |||
| 0.057 | 0.028 | 0.057 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.047 | 0.019 | 0.047 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.064 | 0.036 | 0.064 | Collagenase 3 inhibitor | |||
| 0.132 | 0.104 | 0.132 | Growth hormone agonist | |||
| 0.057 | 0.029 | 0.102 | Heparanase inhibitor | 0.102 0.004 CID_131769945 | CID_131769945 | |
| 0.067 | 0.039 | 0.067 | Beta 3 adrenoreceptor antagonist | |||
| 0.059 | 0.034 | 0.059 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.058 | 0.033 | 0.092 | Adenine nucleotide translocase inhibitor | 0.092 0.005 CID_131769945 | CID_131769945 | |
| 0.092 | 0.068 | 0.092 | Interleukin 12 antagonist | |||
| 0.043 | 0.019 | 0.043 | Leukotriene C4 antagonist | |||
| 0.041 | 0.018 | 0.041 | Fumarate hydratase inhibitor | |||
| 0.046 | 0.024 | 0.046 | Erythropoietin receptor agonist | |||
| 0.066 | 0.043 | 0.066 | CDC25B inhibitor | |||
| 0.051 | 0.028 | 0.051 | Potassium channel Kv1.3 blocker | |||
| 0.096 | 0.074 | 0.096 | Carbonic anhydrase XV inhibitor | |||
| 0.027 | 0.005 | 0.027 | Estrogen-related receptor gamma agonist | |||
| 0.083 | 0.062 | 0.083 | Androgen antagonist | |||
| 0.115 | 0.094 | 0.115 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.055 | 0.035 | 0.055 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.042 | 0.021 | 0.042 | Farnesoid X receptor agonist | |||
| 0.039 | 0.019 | 0.039 | Glutamate (mGluR8) antagonist | |||
| 0.039 | 0.019 | 0.039 | RNA-directed RNA polymerase inhibitor | |||
| 0.055 | 0.035 | 0.055 | Acetyl-CoA transferase inhibitor | |||
| 0.032 | 0.012 | 0.032 | Prostaglandin H2 antagonist | |||
| 0.041 | 0.022 | 0.041 | VCAM-1 antagonist | |||
| 0.026 | 0.006 | 0.026 | Retinoid X beta receptor antagonist | |||
| 0.041 | 0.022 | 0.041 | VCAM antagonist | |||
| 0.037 | 0.019 | 0.037 | HMG CoA reductase inhibitor | |||
| 0.051 | 0.033 | 0.051 | Squalene epoxidase inhibitor | |||
| 0.131 | 0.114 | 0.131 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.063 | 0.046 | 0.063 | Calcium channel P-type blocker | |||
| 0.035 | 0.019 | 0.035 | Carboxypeptidase B inhibitor | |||
| 0.038 | 0.021 | 0.038 | AMPA receptor agonist | |||
| 0.03 | 0.013 | 0.03 | Retinoid X gamma receptor antagonist | |||
| 0.023 | 0.007 | 0.04 | Ileal bile acid transport inhibitor | 0.04 0.004 CID_131769945 | CID_131769945 | |
| 0.021 | 0.005 | 0.021 | Egl nine homolog 1 inhibitor | |||
| 0.053 | 0.037 | 0.084 | Alpha-mannosidase inhibitor | 0.084 0.01 CID_131769945 | CID_131769945 | |
| 0.034 | 0.019 | 0.034 | HCV NS5B polymerase inhibitor | |||
| 0.025 | 0.01 | 0.025 | Isoleucine-tRNA ligase inhibitor | |||
| 0.072 | 0.057 | 0.072 | Carbonic anhydrase XIII inhibitor | |||
| 0.028 | 0.013 | 0.033 | Vanilloid 2 agonist | 0.033 0.007 CID_131769945 | CID_131769945 | |
| 0.045 | 0.031 | 0.045 | Beta adrenoreceptor agonist | |||
| 0.043 | 0.029 | 0.043 | Oxytocin agonist | |||
| 0.033 | 0.021 | 0.033 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.054 | 0.042 | 0.06 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.06 0.034 CID_131769945 | CID_131769945 | |
| 0.076 | 0.064 | 0.086 | Glycine receptor antagonist | 0.086 0.048 CID_131769945 | CID_131769945 | |
| 0.035 | 0.023 | 0.035 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.02 | 0.009 | 0.02 | G-protein-coupled receptor 120 agonist | |||
| 0.031 | 0.02 | 0.031 | Factor VII inhibitor | |||
| 0.177 | 0.166 | 0.177 | Neuropeptide Y2 antagonist | |||
| 0.101 | 0.09 | 0.101 | MAO inhibitor | |||
| 0.017 | 0.006 | 0.017 | Integrin beta6 antagonist | |||
| 0.075 | 0.065 | 0.075 | Adrenaline agonist | |||
| 0.04 | 0.03 | 0.04 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.031 | 0.021 | 0.031 | Prostaglandin agonist | |||
| 0.019 | 0.01 | 0.019 | Nicotinic acid receptor 1 antagonist | |||
| 0.028 | 0.019 | 0.028 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.052 | 0.044 | 0.052 | Xanthine dehydrogenase inhibitor | |||
| 0.113 | 0.107 | 0.113 | Nav1.6 sodium channel blocker | |||
| 0.046 | 0.04 | 0.046 | Bombesin 2 receptor antagonist | |||
| 0.064 | 0.059 | 0.064 | Exportin-1 inhibitor | |||
| 0.052 | 0.047 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.031 | 0.026 | 0.031 | Catechol O-methyltransferase inhibitor | |||
| 0.034 | 0.029 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.03 | 0.026 | 0.03 | Prostacyclin antagonist | |||
| 0.008 | 0.004 | 0.008 | Integrin alpha5beta6 antagonist | |||
| 0.019 | 0.015 | 0.019 | Retinoic acid alpha receptor antagonist | |||
| 0.068 | 0.064 | 0.11 | Topoisomerase II alpha inhibitor | 0.11 0.034 CID_131769945 | CID_131769945 | |
| 0.031 | 0.027 | 0.031 | Estrogen-related receptor beta antagonist | |||
| 0.025 | 0.021 | 0.08 | Sodium/glucose cotransporter 2 inhibitor | 0.08 0.004 CID_131769945 | CID_131769945 | |
| 0.06 | 0.056 | 0.06 | Beta adrenoreceptor antagonist | |||
| 0.018 | 0.015 | 0.018 | 5-Alpha-reductase 2 inhibitor | |||
| 0.059 | 0.056 | 0.059 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.046 | 0.043 | 0.046 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.024 | 0.021 | 0.066 | Sodium/glucose cotransporter inhibitor | 0.066 0.004 CID_131769945 | CID_131769945 | |
| 0.134 | 0.131 | 0.134 | Psychostimulant | |||
| 0.053 | 0.051 | 0.053 | Pregnane X receptor antagonist | |||
| 0.093 | 0.09 | 0.093 | Anesthetic local | |||
| 0.032 | 0.03 | 0.032 | Nicotinic acid receptor 2 agonist | |||
| 0.018 | 0.016 | 0.018 | Caspase 8 inhibitor | |||
| 0.038 | 0.036 | 0.038 | Guanylate cyclase inhibitor | |||
| 0.014 | 0.012 | 0.014 | Calcium-sensing receptor antagonist | |||
| 0.02 | 0.018 | 0.02 | Glutamate (mGluR1a) agonist | |||
| 0.054 | 0.053 | 0.054 | NMDA receptor glycine site agonist | |||
| 0.036 | 0.035 | 0.036 | Vanilloid 3 antagonist | |||
| 0.077 | 0.076 | 0.077 | CC chemokine 5 receptor agonist | |||
| 0.01 | 0.009 | 0.01 | Thromboxane agonist | |||
| 0.02 | 0.019 | 0.02 | Leukotriene B4 receptor 2 antagonist | 0.02 0.018 CID_131769945 | ||
| 0.053 | 0.052 | 0.053 | Androgen agonist | |||
| 0.015 | 0.016 | 0.016 | Telomerase stimulant | 0.016 0.015 CID_131769945 | CID_131769945 | |
| 0.039 | 0.042 | 0.079 | Mannosidase inhibitor | 0.079 0.009 CID_131769945 | CID_131769945 | |
| 0.095 | 0.097 | 0.14 | Beta amyloid protein antagonist | 0.14 0.048 CID_131769945 | CID_131769945 | |
| 0.017 | 0.02 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.008 CID_131769945 | CID_131769945 | |
| 0.036 | 0.042 | 0.073 | Phosphorylase inhibitor | 0.073 0.019 CID_131769945 | CID_131769945 | |
| 0.023 | 0.031 | 0.053 | Squalene synthetase inhibitor | 0.053 0.014 CID_131769945 | CID_131769945 | |
| 0.052 | 0.061 | 0.074 | Lipocortins synthesis agonist | 0.074 0.018 CID_131769945 | CID_131769945 | |
| 0.112 | 0.123 | 0.266 | Anticoagulant | 0.266 0.035 CID_131769945 | CID_131769945 | |
| 0.114 | 0.128 | 0.386 | Hemostatic | 0.386 0.009 CID_131769945 | CID_131769945 | |
| 0.072 | 0.094 | 0.188 | Transcription factor NF kappa B stimulant | 0.188 0.01 CID_131769945 | CID_131769945 | |
| 0.021 | 0.047 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.021 CID_131769945 | CID_131769945 | |
| 0.049 | 0.085 | 0.169 | Antineoplastic antibiotic | 0.169 0.027 CID_131769945 | CID_131769945 | |
| 0.036 | 0.077 | 0.099 | Factor IXa inhibitor | 0.099 0.01 CID_131769945 | CID_131769945 | |
| 0.03 | 0.081 | 0.088 | Protein 50S ribosomal subunit inhibitor | 0.088 0.016 CID_131769945 | CID_131769945 | |
| 0.013 | 0.081 | 0.03 | Caspase 2 inhibitor | 0.03 0.023 CID_131769945 | CID_131769945 | |
| 0.042 | 0.111 | 0.11 | Neuraminidase (influenza) inhibitor | 0.11 0.014 CID_131769945 | CID_131769945 | |
| 0.065 | 0.133 | 0.168 | Topoisomerase II inhibitor | 0.168 0.042 CID_131769945 | CID_131769945 | |
| 0.092 | 0.164 | 0.125 | DNA repair enzyme inhibitor | 0.125 0.064 CID_131769945 | CID_131769945 | |
| 0.018 | 0.103 | 0.035 | Toll-Like receptor 4 agonist | 0.035 0.007 CID_131769945 | CID_131769945 | |
| 0.023 | 0.114 | 0.044 | Neuraminidase (Influenza A) inhibitor | 0.044 0.035 CID_131769945 | CID_131769945 | |
| 0.026 | 0.12 | 0.087 | Neuraminidase inhibitor | 0.087 0.021 CID_131769945 | CID_131769945 | |
| 0.082 | 0.19 | 0.115 | Diuretic | 0.115 0.111 CID_131769945 | CID_131769945 | |
| 0.045 | 0.156 | 0.118 | Topoisomerase I inhibitor | 0.118 0.057 CID_131769945 | CID_131769945 | |
| 0.145 | 0.269 | 0.279 | Alpha-glucosidase inhibitor | 0.279 0.171 CID_131769945 | CID_131769945 | |
| 0.148 | 0.278 | 0.276 | Antiobesity | 0.276 0.134 CID_131769945 | CID_131769945 | |
| 0.129 | 0.273 | 0.252 | Angiogenesis inhibitor | 0.252 0.122 CID_131769945 | CID_131769945 | |
| 0.084 | 0.283 | 0.179 | Vasodilator | 0.179 0.123 CID_131769945 | CID_131769945 | |
| 0.017 | 0.231 | 0.065 | Antibiotic Aminoglycoside-like | 0.065 0.007 CID_131769945 | CID_131769945 | |
| 0.028 | 0.254 | 0.073 | Histone deacetylase SIRT1 stimulant | 0.073 0.052 CID_131769945 | CID_131769945 | |
| 0.028 | 0.254 | 0.073 | Histone deacetylase stimulant | 0.073 0.052 CID_131769945 | CID_131769945 | |
| 0.008 | 0.252 | 0.029 | Protein 30S ribosomal subunit inhibitor | 0.029 0.013 CID_131769945 | CID_131769945 | |
| 0.092 | 0.374 | 0.127 | CC chemokine 6 receptor antagonist | 0.127 0.083 CID_131769945 | CID_131769945 | |
| 0.057 | 0.379 | 0.388 | Tumour necrosis factor alpha release inhibitor | 0.388 0.029 CID_131769945 | CID_131769945 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |